SynthesisAlimentary pharmacology & therapeutics2022

Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-effects on gastrointestinal symptoms and rectal biomarkers of immune activity.

Valeria Castro Tejera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.